Earle A Chiles Research Institute — Portland, Oregon

Earle A Chiles Research Institute is a clinical research site located in Portland, Oregon, United States 97213.

Crixeo Clinical Trials Trust Score: 14/100 (FAILING). This profile has not yet been claimed by the site owner.

Earle A Chiles Research Institute has participated in 4 clinical trials with 1 currently active.

Therapeutic areas: Non-Small-Cell Lung Carcinoma, Neoplasm Recurrence, Local, Locally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma or Cancer.

Sponsors: Genentech, Inc., Astellas Pharma Global Development, Inc., Argos Therapeutics.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Portland

Browse all research sites in Oregon · View every site in Portland

Sponsor Feasibility Report

Trust Score: 14/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Earle A Chiles Research Institute?

Earle A Chiles Research Institute has a Crixeo Trust Score of 14/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Earle A Chiles Research Institute conducted?

Earle A Chiles Research Institute has 4 clinical trials on record, with 1 currently active. Their work covers Non-Small-Cell Lung Carcinoma, Neoplasm Recurrence, Local, Locally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma or Cancer.

Is Earle A Chiles Research Institute accredited by Crixeo Clinical Trials?

Earle A Chiles Research Institute has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Earle A Chiles Research Institute?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.